CN1857278A - Externally applied compound gel and its preparing method - Google Patents
Externally applied compound gel and its preparing method Download PDFInfo
- Publication number
- CN1857278A CN1857278A CN 200610024744 CN200610024744A CN1857278A CN 1857278 A CN1857278 A CN 1857278A CN 200610024744 CN200610024744 CN 200610024744 CN 200610024744 A CN200610024744 A CN 200610024744A CN 1857278 A CN1857278 A CN 1857278A
- Authority
- CN
- China
- Prior art keywords
- carbomer
- tinea
- compound gel
- add
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- 208000002474 Tinea Diseases 0.000 claims abstract description 11
- 206010017533 Fungal infection Diseases 0.000 claims abstract description 6
- 208000010195 Onychomycosis Diseases 0.000 claims abstract description 6
- 201000005882 tinea unguium Diseases 0.000 claims abstract description 6
- 206010005913 Body tinea Diseases 0.000 claims abstract description 5
- 206010043866 Tinea capitis Diseases 0.000 claims abstract description 5
- 201000010618 Tinea cruris Diseases 0.000 claims abstract description 5
- 206010067197 Tinea manuum Diseases 0.000 claims abstract description 5
- 201000003875 tinea corporis Diseases 0.000 claims abstract description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 29
- 229920002125 Sokalan® Polymers 0.000 claims description 29
- 229960001631 carbomer Drugs 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 21
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 17
- 229960004703 clobetasol propionate Drugs 0.000 claims description 13
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 9
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 9
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 8
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 3
- 229960003415 propylparaben Drugs 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 2
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- 239000008215 water for injection Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 8
- 230000002421 anti-septic effect Effects 0.000 claims 4
- 239000000080 wetting agent Substances 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 3
- 230000000813 microbial effect Effects 0.000 claims 2
- 241000130764 Tinea Species 0.000 claims 1
- 238000013019 agitation Methods 0.000 claims 1
- 239000011324 bead Substances 0.000 claims 1
- 229910000397 disodium phosphate Inorganic materials 0.000 claims 1
- 235000019800 disodium phosphate Nutrition 0.000 claims 1
- 210000002683 foot Anatomy 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 201000004647 tinea pedis Diseases 0.000 claims 1
- 241000893966 Trichophyton verrucosum Species 0.000 abstract description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract description 4
- 241000233866 Fungi Species 0.000 abstract description 4
- 208000017520 skin disease Diseases 0.000 abstract 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 19
- 229960000699 terbinafine hydrochloride Drugs 0.000 description 19
- 239000011159 matrix material Substances 0.000 description 15
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 12
- 238000001914 filtration Methods 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 7
- 230000002538 fungal effect Effects 0.000 description 6
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 4
- 235000019445 benzyl alcohol Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 229940031439 squalene Drugs 0.000 description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 102000005782 Squalene Monooxygenase Human genes 0.000 description 1
- 108020003891 Squalene monooxygenase Proteins 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000008686 ergosterol biosynthesis Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种复方外用凝胶及其制法,目的是提供一种以盐酸特比奈芬(Terbinafine Hydrochloride,TER-HCL)和丙酸氯倍他索(Clobetasol Propionate,CBT)为主要成分的,可治疗癣病(体癣 股癣 手足癣和头癣等)、念珠菌引起的皮肤酵母菌感染,以及由发霉菌引起的甲癣等疾病的外用凝胶及其制备方法。本发明使用方便、治愈率高,适合于皮肤病患者使用。The present invention relates to a compound external gel and its preparation method. The external gel and the preparation method thereof can be used for treating ringworm (tinea corporis, tinea cruris, tinea manus, tinea capitis, etc.), skin yeast infection caused by candida, and onychomycosis caused by fungus. The invention is convenient to use and has a high cure rate, and is suitable for skin disease patients.
Description
技术领域technical field
本发明涉及一种新型药物剂型,具体为一种治疗癣病(体癣、股癣、手足癣和头癣等)、念珠菌引起的皮肤酵母菌感染,以及由发霉菌引起的甲癣等疾病的外用复方凝胶及其制备方法。The invention relates to a new type of pharmaceutical dosage form, in particular to a treatment for ringworm (tinea corporis, jock itch, tinea manuum, tinea capitis, etc.), skin yeast infection caused by Candida, and onychomycosis caused by moldy fungus and other diseases Compound gel for external use and preparation method thereof.
背景技术Background technique
盐酸特比奈芬(Terbinafine Hydrochloride,TER-HCL)具有特异性抑制角鲨烯环氧化酶的作用,真菌细胞不断摄取角鲨烯,导致细胞膜破坏,致真菌细胞死亡,此为它的杀菌作用。另外,角鲨烯环氧化酶为麦角固醇形成的关键酶,由于角鲨烯不能环氧化致使敏感真菌细胞膜主要构成物即麦角固醇合成减少,从而抑制真菌细胞活性,此为它的抑菌作用。因此,盐酸特比奈芬的作用机制是选择性地抑制真菌合成和繁殖过程中所必需的氧化酶,从而达到杀菌和抑制真菌的双重作用,它还同时具有广谱抗真菌的作用。Terbinafine Hydrochloride (TER-HCL) has the effect of specifically inhibiting squalene cyclooxygenase. Fungal cells continuously ingest squalene, resulting in cell membrane damage and fungal cell death. This is its bactericidal effect. In addition, squalene epoxidase is the key enzyme for the formation of ergosterol. Since squalene cannot be epoxidized, the synthesis of ergosterol, the main component of the sensitive fungal cell membrane, is reduced, thereby inhibiting the activity of fungal cells. This is its Antibacterial effect. Therefore, the mechanism of action of terbinafine hydrochloride is to selectively inhibit the necessary oxidase in the process of fungal synthesis and reproduction, so as to achieve the dual effects of bactericidal and fungal inhibition, and it also has a broad-spectrum antifungal effect.
丙酸氯倍他索(Clobetasol Propionate,CBT)为肾上腺皮质激素类药物,具有较强的抗炎、抗瘙痒和血管收缩作用,临床用于治疗神经性皮炎、接触性皮炎、脂溢性皮炎等症。Clobetasol propionate (Clobetasol Propionate, CBT) is an adrenal cortex hormone drug, which has strong anti-inflammatory, anti-itching and vasoconstrictive effects, and is clinically used to treat neurodermatitis, contact dermatitis, seborrheic dermatitis, etc. disease.
本发明涉及的水性凝胶基质,具有易涂展,易洗除,无油腻感,能吸收组织渗出液而不妨碍皮肤正常功能的作用,同时,由于该基质的粘滞度较小,有利于药物的快速释放。The aqueous gel matrix involved in the present invention has the functions of being easy to spread, easy to wash and remove, no greasy feeling, and capable of absorbing tissue exudate without hindering the normal function of the skin. At the same time, due to the low viscosity of the matrix, it has Facilitate rapid drug release.
由盐酸特比奈芬和丙酸氯倍他索为主要成分制成外用复方凝胶,可起到高效杀菌的作用,且涂抹方便舒适无刺激性,适合于患有癣病、皮肤酵母菌感染,以及甲癣等疾病的患者使用。The compound gel for external use is made of terbinafine hydrochloride and clobetasol propionate as the main ingredients, which can effectively sterilize bacteria, and is convenient and comfortable to apply without irritation. It is suitable for people with ringworm and skin yeast infection. And patients with diseases such as onychomycosis.
但目前临床上尚缺少一种能治疗癣病(体癣、股癣、手足癣和头癣等)、念珠菌引起的皮肤酵母菌感染,以及由发霉菌引起的甲癣等疾病的外用复方凝胶。But there is still a lack of a kind of external compound condensate that can treat ringworm (tinea corporis, jock itch, tinea manuum and tinea capitis, etc.), skin yeast infection caused by Candida, and diseases such as onychomycosis caused by moldy fungi at present. glue.
发明内容Contents of the invention
本发明的目的是提供一种治疗癣病(体癣、股癣、手足癣和头癣等)、念珠菌引起的皮肤酵母菌感染,以及由发霉菌引起的甲癣等疾病的外用复方凝胶及其制备方法。The object of the present invention is to provide a kind of compound gel for external use for the treatment of ringworm (tinea corporis, jock itch, tinea manuum and tinea capitis, etc.), skin yeast infection caused by candida, and onychomycosis caused by moldy fungus and its preparation method.
本发明涉及一种外用复方凝胶剂,其特征在于处方主要成分为盐酸特比奈芬(0.01~20)%,丙酸氯倍他索(0.01~10)%,以及其他成分包括:卡波姆(0.1~5)%、羟丙甲基纤维素(0~20)%、pH调节剂(0.5~10)%、保湿剂(5~30)%、溶剂(10~80)%、防腐剂(0.01~1.5)%。The invention relates to a compound gel for external use, which is characterized in that the main ingredients of the prescription are terbinafine hydrochloride (0.01-20)%, clobetasol propionate (0.01-10)%, and other ingredients include: carbomer (0.1~5)%, hydroxypropyl methylcellulose (0~20)%, pH adjuster (0.5~10)%, humectant (5~30)%, solvent (10~80)%, preservative ( 0.01~1.5)%.
其中:所述pH调节剂包括但不仅限于磷酸氢二钠、磷酸二氢钠、三乙醇胺、乙二胺、月桂胺、碳酸氢钠、氢氧化钠等,可以单独或组合应用。Wherein: the pH regulator includes but not limited to disodium hydrogen phosphate, sodium dihydrogen phosphate, triethanolamine, ethylenediamine, laurylamine, sodium bicarbonate, sodium hydroxide, etc., which can be used alone or in combination.
所述保湿剂包括但不仅限于甘油、丙二醇、山梨醇、二甘醇、木糖醇等,可以单独或组合应用。The humectants include but are not limited to glycerin, propylene glycol, sorbitol, diethylene glycol, xylitol, etc., which can be used alone or in combination.
所述溶剂包括但不仅限于丙二醇、乙醇、纯化水、蒸馏水、注射用水等,可以单独或组合应用。The solvents include but are not limited to propylene glycol, ethanol, purified water, distilled water, water for injection, etc., and can be used alone or in combination.
所述防腐剂包括但不仅限于苯甲醇、尼泊金甲酯、尼泊金丙酯、尼泊金丁酯等,可以单独或组合应用。The preservatives include but are not limited to benzyl alcohol, methylparaben, propylparaben, butylparaben, etc., which can be used alone or in combination.
该剂型具体的制备方法如下所述:The specific preparation method of this dosage form is as follows:
第一步 取卡波姆,加保湿剂研磨润湿后,加适量水使卡波姆得以充分溶胀,得卡波姆基质;The first step is to take carbomer, add a moisturizer to grind and moisten it, then add an appropriate amount of water to fully swell the carbomer to obtain a carbomer matrix;
第二步 取羟丙甲基纤维素,加适量90℃水并快速搅拌,得均匀白色羟丙甲基纤维素溶液,将其加入卡波姆基质中混匀备用;The second step is to take hydroxypropyl methylcellulose, add an appropriate amount of water at 90°C and stir quickly to obtain a uniform white hydroxypropyl methylcellulose solution, add it to the carbomer matrix and mix well for later use;
第三步 取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入第二步所得基质中;The third step is to take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the matrix obtained in the second step while stirring;
第四步 向第三步所得混合物中滴加pH调节剂溶液和防腐剂,再以水加至全量,并搅拌均匀;The fourth step is to add the pH regulator solution and preservative to the mixture obtained in the third step, and then add water to the full amount, and stir evenly;
第五步 将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。The fifth step is to carry out primary filtration and fine filtration of the above liquid, and then fill it to obtain the compound gel for external use of the present invention.
本发明为水性凝胶剂,具有无油腻感,能吸收组织渗出液而不妨碍皮肤正常功能的作用,同时,由于该基质的粘滞度较小,有利于药物的快速释放。同时,该制剂给药后,易涂展和洗除,易于被患者接收,有助于提高患者的用药依从性,是一种有效的新型临床抗感染制剂。The invention is a water-based gel, which has no greasy feeling, can absorb tissue exudate without hindering the normal function of the skin, and at the same time, because the viscosity of the matrix is small, it is beneficial to the rapid release of drugs. At the same time, after the preparation is administered, it is easy to spread and wash off, and is easy to be accepted by patients, which helps to improve the medication compliance of patients, and is an effective new clinical anti-infection preparation.
具体实施方式Detailed ways
本发明所述外用复方凝胶剂包括主要成分盐酸特比奈芬和丙酸氯倍他索,以及卡波姆、羟丙甲基纤维素、pH调节剂、保湿剂、溶剂、防腐剂等,经过特定方法制备而得。为更好的说明本发明所述的外用复方凝胶剂的制备方法,特举例如下:The compound gel for external use of the present invention comprises main components terbinafine hydrochloride and clobetasol propionate, and carbomer, hypromellose, pH regulator, humectant, solvent, preservative, etc., after Prepared by a specific method. For a better description of the preparation method of the external compound gel of the present invention, special examples are as follows:
实施例1.外用复方凝胶剂的制备Embodiment 1. The preparation of compound gel for external use
处方:盐酸特比奈芬 1.0gPrescription: Terbinafine Hydrochloride 1.0g
丙酸氯倍他索 0.03g
卡波姆941 0.5gCarbomer 941 0.5g
羟丙甲基纤维素 10.0g
三乙醇胺 1.5g
甘油 15.0gGlycerin 15.0g
丙二醇 10.0gPropylene Glycol 10.0g
乙醇 10.0mlEthanol 10.0ml
苯甲醇 0.5gBenzyl alcohol 0.5g
纯化水 加至100g
制备方法:Preparation:
1.取卡波姆,加甘油研磨润湿后,加10ml纯化水使卡波姆得以充分溶胀,得卡波姆基质;1. Take carbomer, grind it with glycerin, add 10ml of purified water to fully swell the carbomer, and obtain the carbomer matrix;
2.取羟丙甲基纤维素,加15ml的90℃水并快速搅拌,得均匀白色羟丙甲基纤维素溶液,将其加入卡波姆基质中混匀备用;2. Take hydroxypropyl methylcellulose, add 15ml of 90°C water and stir quickly to obtain a uniform white hydroxypropyl methylcellulose solution, add it to the carbomer matrix and mix well for later use;
3.取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入卡波姆基质中;3. Take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the carbomer matrix under stirring;
4.取丙二醇缓缓加入上一步所得混合物中,并搅拌均匀;4. Slowly add propylene glycol to the mixture obtained in the previous step, and stir evenly;
5.向上一步所得混合物中滴加三乙醇胺、苯甲醇,再以纯化水加至全量,并搅拌均匀;5. Add triethanolamine and benzyl alcohol dropwise to the mixture obtained in the previous step, then add purified water to the full amount, and stir evenly;
6.将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。总量100g,共分装为10支,每支10g,盐酸特比奈芬含量0.1g/10g。6. The above-mentioned liquid is subjected to initial filtration and fine filtration, and then filled to obtain the compound gel for external use of the present invention. The total amount is 100g, divided into 10 sticks, each stick is 10g, and the content of terbinafine hydrochloride is 0.1g/10g.
实施例2.外用复方凝胶剂的制备Embodiment 2. The preparation of compound gel for external use
处方:盐酸特比奈芬 1.0gPrescription: Terbinafine Hydrochloride 1.0g
丙酸氯倍他索 0.03g
卡波姆941 1.5gCarbomer 941 1.5g
三乙醇胺 2.5g
甘油 10.0gGlycerin 10.0g
二甘醇 10.0gDiethylene glycol 10.0g
乙醇 10.0mlEthanol 10.0ml
苯甲醇 0.5gBenzyl alcohol 0.5g
蒸馏水 加至100gDistilled water Add up to 100g
制备方法:Preparation:
1.取卡波姆,加甘油研磨润湿后,加20ml蒸馏水使卡波姆得以充分溶胀,得卡波姆基质;1. Take carbomer, add glycerin to grind and moisten it, add 20ml of distilled water to fully swell the carbomer, and obtain the carbomer matrix;
2.取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入卡波姆基质中;2. Take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the carbomer matrix under stirring;
3.取二甘醇缓缓加入上一步所得混合物中,并搅拌均匀;3. Slowly add diethylene glycol to the mixture obtained in the previous step, and stir evenly;
4.向上一步所得混合物中滴加三乙醇胺、苯甲醇,再以蒸馏水加至全量,并搅拌均匀;4. Add triethanolamine and benzyl alcohol dropwise to the mixture obtained in the previous step, then add distilled water to the full amount, and stir evenly;
5.将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。总量100g,共分装为10支,每支10g,盐酸特比奈芬含量0.1g/10g。5. The above-mentioned liquid is subjected to primary filtration and fine filtration, and then filled to obtain the compound gel for external use of the present invention. The total amount is 100g, divided into 10 sticks, each stick is 10g, and the content of terbinafine hydrochloride is 0.1g/10g.
实施例3.外用复方凝胶剂的制备Embodiment 3. Preparation of compound gel for external use
处方:盐酸特比奈芬 1.0gPrescription: Terbinafine Hydrochloride 1.0g
丙酸氯倍他索 0.05g
卡波姆941 1.5gCarbomer 941 1.5g
碳酸氢钠 2.5gSodium bicarbonate 2.5g
二甘醇 10.0gDiethylene glycol 10.0g
山梨醇 10.0gSorbitol 10.0g
乙醇 10.0mlEthanol 10.0ml
尼泊金甲酯 0.1gMethylparaben 0.1g
纯化水 加至100g
制备方法:Preparation:
1.取卡波姆,加二甘醇研磨润湿后,加20ml纯化水使卡波姆得以充分溶胀,得卡波姆基质;1. Take carbomer, add diethylene glycol to grind and moisten it, add 20ml of purified water to fully swell the carbomer, and obtain the carbomer matrix;
2.取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入卡波姆基质中;2. Take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the carbomer matrix under stirring;
3.取丙二醇缓缓加入第二步所得混合物中,并搅拌均匀;3. Slowly add propylene glycol to the mixture obtained in the second step, and stir evenly;
4.向上一步所得混合物中滴加三乙醇胺、尼泊金甲酯,再以纯化水加至全量,并搅拌均匀;4. Add triethanolamine and methylparaben dropwise to the mixture obtained in the previous step, then add purified water to the full amount, and stir evenly;
5.将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。总量100g,共分装为10支,每支10g,盐酸特比奈芬含量0.1g/10g。5. The above-mentioned liquid is subjected to primary filtration and fine filtration, and then filled to obtain the compound gel for external use of the present invention. The total amount is 100g, divided into 10 sticks, each stick is 10g, and the content of terbinafine hydrochloride is 0.1g/10g.
实施例4.外用复方凝胶剂的制备Embodiment 4. Preparation of compound gel for external use
处方:盐酸特比奈芬 1.0gPrescription: Terbinafine Hydrochloride 1.0g
丙酸氯倍他索 0.03g
卡波姆941 1.5gCarbomer 941 1.5g
氢氧化钠 2.5gSodium Hydroxide 2.5g
甘油 20.0gGlycerin 20.0g
乙醇 10.0mlEthanol 10.0ml
尼泊金丙酯 0.01g
蒸馏水 加至100gDistilled water Add up to 100g
制备方法:Preparation:
1.取卡波姆,加甘油研磨润湿后,加20ml蒸馏水使卡波姆得以充分溶胀,得卡波姆基质;1. Take carbomer, add glycerin to grind and moisten it, add 20ml of distilled water to fully swell the carbomer, and obtain the carbomer matrix;
2.取盐酸特比奈芬和丙酸氯倍他索,以乙醇溶解后,在搅拌下缓缓加入卡波姆基质中;2. Take terbinafine hydrochloride and clobetasol propionate, dissolve them in ethanol, and slowly add them to the carbomer matrix under stirring;
3.向上一步所得混合物中滴加氢氧化钠、尼泊金丙酯,再以蒸馏水加至全量,并搅拌均匀;3. Add sodium hydroxide and propylparaben dropwise to the mixture obtained in the previous step, then add distilled water to the full amount, and stir evenly;
4.将上述液体进行初滤和精滤,再进行灌装即得本发明所述的外用复方凝胶。总量100g,共分装为10支,每支10g,盐酸特比奈芬含量0.1g/10g。4. The above-mentioned liquid is subjected to initial filtration and fine filtration, and then filled to obtain the compound gel for external use of the present invention. The total amount is 100g, divided into 10 sticks, each stick is 10g, and the content of terbinafine hydrochloride is 0.1g/10g.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100247442A CN100443085C (en) | 2006-03-16 | 2006-03-16 | A kind of compound gel for external use and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100247442A CN100443085C (en) | 2006-03-16 | 2006-03-16 | A kind of compound gel for external use and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1857278A true CN1857278A (en) | 2006-11-08 |
CN100443085C CN100443085C (en) | 2008-12-17 |
Family
ID=37296266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100247442A Expired - Fee Related CN100443085C (en) | 2006-03-16 | 2006-03-16 | A kind of compound gel for external use and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100443085C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107158273A (en) * | 2017-06-08 | 2017-09-15 | 苏州凌科特新材料有限公司 | Medical disinfection gel and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1524531A (en) * | 2003-02-24 | 2004-09-01 | 北京亚科希药物研究所 | Compound terbinafine hydrochloride composition of skin antibacterial drugs |
CN1272012C (en) * | 2003-06-23 | 2006-08-30 | 北京亚科希药物研究所 | Dermatopathy therapeutic medicine compositions and its preparation method |
AU2005258903A1 (en) * | 2004-07-02 | 2006-01-12 | Warner-Lambert Company Llc | Compositions and methods for treating pathological infections |
-
2006
- 2006-03-16 CN CNB2006100247442A patent/CN100443085C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107158273A (en) * | 2017-06-08 | 2017-09-15 | 苏州凌科特新材料有限公司 | Medical disinfection gel and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN100443085C (en) | 2008-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101032474A (en) | Rasagiline transparent patch for curing and preventing neurological diseases and the preparing method thereof | |
CN1679472A (en) | Antimycotic nail varnish composition | |
CN1324607A (en) | Anti-fungus agent for local treatment of fungus infection of finger and its peripheral tissue and controllable releasable system of keratin-dissolving agnt | |
CN1899291A (en) | External use antifungal compound composition and its use | |
CN1679520A (en) | A kind of compound analgesic cataplasm | |
CN101455654A (en) | Arginine ibuprofen gel and preparation method thereof | |
CN1316965C (en) | Transparent disappearing external administration carrier | |
CN1927181A (en) | Terbinafine nano milk-like liquid antifungal medicine and its preparation | |
CN1857278A (en) | Externally applied compound gel and its preparing method | |
CN1931165A (en) | Nanometer antifungal econazole nitrate emulsion medicine and its prepn process | |
CN110693860B (en) | Gel plaster containing ketoprofen and preparation method thereof | |
CN1151866A (en) | Topical therapeutic composition for dermatitis | |
CN1943676A (en) | Baiying gel and its preparation method and application | |
CN1543943A (en) | Oral silymarin sustained-release preparation and preparation method thereof | |
CN1861059A (en) | Hydrophilic gel type percutaneous plaster contg. capsaicin, and its prepn. method | |
CN1762349A (en) | Externally applied ointment of ketorolac tromethamine and its preparation method | |
CN1480130A (en) | Ointment for anti-inflammation, analgesia and rheumatism dispelling and preparation method thereof | |
CN1559410A (en) | Itraconazole soft capsule and preparation method thereof | |
CN1957942A (en) | External preparation of Levocetirizine hydrochloric acid | |
CN1457765A (en) | Cetirizine hydrochloride gel | |
CN1634062A (en) | Nalmefene Hydrochloride Nasal Administration Preparation | |
CN1460472A (en) | Biquanide vanadium complex plaster preparation for curing diabetes and its application | |
CN1272012C (en) | Dermatopathy therapeutic medicine compositions and its preparation method | |
CN1714787A (en) | Tromethamine gel form medicinal composition | |
CN1634071A (en) | A kind of gel for treating glaucoma and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081217 Termination date: 20130316 |